Canada markets closed

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4600+0.1000 (+2.98%)
At close: 04:00PM EDT
3.5800 +0.12 (+3.47%)
After hours: 05:36PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 423.37M
Enterprise Value 247.92M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)10.90
Price/Book (mrq)11.47
Enterprise Value/Revenue 6.73
Enterprise Value/EBITDA -1.49

Trading Information

Stock Price History

Beta (5Y Monthly) 1.51
52-Week Change 3-54.72%
S&P500 52-Week Change 322.38%
52 Week High 39.6200
52 Week Low 30.8010
50-Day Moving Average 34.3342
200-Day Moving Average 32.5534

Share Statistics

Avg Vol (3 month) 32.25M
Avg Vol (10 day) 31.86M
Shares Outstanding 5122.36M
Implied Shares Outstanding 6122.36M
Float 864.8M
% Held by Insiders 11.32%
% Held by Institutions 194.28%
Shares Short (Apr 15, 2024) 410.58M
Short Ratio (Apr 15, 2024) 45.08
Short % of Float (Apr 15, 2024) 411.38%
Short % of Shares Outstanding (Apr 15, 2024) 48.65%
Shares Short (prior month Mar 15, 2024) 48.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-195.57%

Management Effectiveness

Return on Assets (ttm)-38.13%
Return on Equity (ttm)-266.24%

Income Statement

Revenue (ttm)36.85M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)-27.10%
Gross Profit (ttm)N/A
EBITDA -169.44M
Net Income Avi to Common (ttm)-171.67M
Diluted EPS (ttm)-1.4800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)209.08M
Total Cash Per Share (mrq)1.72
Total Debt (mrq)33.83M
Total Debt/Equity (mrq)91.67%
Current Ratio (mrq)3.36
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-168.88M
Levered Free Cash Flow (ttm)-85.71M